Mirabella Financial Services LLP Invests $4.29 Million in Cardlytics, Inc. (NASDAQ:CDLX)

Mirabella Financial Services LLP acquired a new position in shares of Cardlytics, Inc. (NASDAQ:CDLX - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 1,155,000 shares of the company's stock, valued at approximately $4,285,000. Mirabella Financial Services LLP owned about 2.27% of Cardlytics at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of CDLX. Intech Investment Management LLC grew its position in shares of Cardlytics by 31.3% in the 4th quarter. Intech Investment Management LLC now owns 19,310 shares of the company's stock valued at $72,000 after purchasing an additional 4,607 shares during the period. SG Americas Securities LLC boosted its holdings in shares of Cardlytics by 38.2% in the fourth quarter. SG Americas Securities LLC now owns 19,490 shares of the company's stock valued at $72,000 after buying an additional 5,392 shares during the period. Check Capital Management Inc. CA boosted its holdings in shares of Cardlytics by 11.0% in the fourth quarter. Check Capital Management Inc. CA now owns 56,200 shares of the company's stock valued at $209,000 after buying an additional 5,550 shares during the period. Wells Fargo & Company MN increased its position in shares of Cardlytics by 46.0% during the fourth quarter. Wells Fargo & Company MN now owns 21,106 shares of the company's stock worth $78,000 after acquiring an additional 6,649 shares in the last quarter. Finally, Global Retirement Partners LLC raised its holdings in shares of Cardlytics by 54.7% during the fourth quarter. Global Retirement Partners LLC now owns 19,800 shares of the company's stock worth $73,000 after acquiring an additional 7,000 shares during the period. Institutional investors and hedge funds own 68.10% of the company's stock.

Insider Buying and Selling

In related news, CEO Amit Gupta sold 15,160 shares of Cardlytics stock in a transaction dated Friday, January 24th. The shares were sold at an average price of $3.92, for a total transaction of $59,427.20. Following the completion of the sale, the chief executive officer now owns 215,494 shares of the company's stock, valued at approximately $844,736.48. The trade was a 6.57 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO Alexis Desieno sold 24,778 shares of the stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $3.40, for a total transaction of $84,245.20. Following the completion of the transaction, the chief financial officer now directly owns 140,948 shares in the company, valued at approximately $479,223.20. This represents a 14.95 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 90,475 shares of company stock worth $314,216. Company insiders own 4.40% of the company's stock.

Cardlytics Stock Up 0.6 %

CDLX traded up $0.01 on Wednesday, hitting $1.55. 478,108 shares of the company were exchanged, compared to its average volume of 1,012,420. The company has a debt-to-equity ratio of 2.40, a quick ratio of 1.18 and a current ratio of 1.18. The stock's fifty day moving average is $2.07 and its 200-day moving average is $3.13. The company has a market cap of $80.73 million, a PE ratio of -0.25 and a beta of 1.39. Cardlytics, Inc. has a 12 month low of $1.22 and a 12 month high of $15.89.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on CDLX shares. Lake Street Capital lowered their target price on Cardlytics from $5.00 to $3.00 and set a "hold" rating for the company in a report on Thursday, March 13th. Needham & Company LLC reiterated a "hold" rating on shares of Cardlytics in a report on Thursday, March 13th. Finally, Evercore ISI cut their target price on Cardlytics from $4.00 to $3.00 and set an "in-line" rating on the stock in a research note on Thursday, March 13th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, Cardlytics currently has a consensus rating of "Hold" and a consensus target price of $6.42.

Cardlytics Profile

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.